Biosynth, a global supplier of critical raw materials and services to the life sciences industry, today announced that its Board of Directors has appointed Matt Gunnison as the company’s new Chief Executive Officer and a member of the Board of Directors, effective immediately. The Board has also appointed Kieran Murphy as Chairman, effective as of […]
Priced at just $169,000 Vega is designed to make highly accurate long-read sequencing accessible to any laboratory MENLO PARK, Calif. — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the Vega™ system, the company’s first benchtop long-read sequencing platform. Vega delivers all the functionality of the Revio system, PacBio’s high-throughput long-read sequencer, […]
Strategic alliance will provide researchers in India, Bangladesh and Nepal with access to a wider range of innovative, biological materials WESTBURY, NY – BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced an exclusive agreement* with KRISHGEN BioSystems, a leading provider of life science research tools and services […]
Grant supports the expansion of their rapid, high-resolution LinkPrep™ technology in transforming cancer research SCOTTS VALLEY, Calif. — Dovetail Genomics, a leading innovator in genomic solutions, is proud to announce the receipt of a $2M (USD) Small Business Innovation Research (SBIR) grant from the National Human Genome Research Institute (NHGRI), under Award Number R44HG014126. Funding […]
VIENNA–Ribbon Bio GmbH, the DNA synthesis company, announced today that John Luckey, Ph.D. has been appointed Chief Technology Officer. Dr. Luckey brings more than 25 years of technology development leadership experience in both start-up and global companies, advancing platforms and systems used in biomedical research and translational medicine, most recently at DNA Script. “We are […]
BOSTON and ROLLE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, today announced the next step in the partnership between the Company and Genomenon, a leading genomic intelligence company, to support better, data-driven outcomes in the rare disease and oncology fields. The two companies have expanded the integration of […]
RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that the Avantor Board of Directors has appointed Dame Louise Makin, DBE, Ph.D., as a director with an initial term expiring at Avantor’s 2025 Annual Meeting of Stockholders. […]
The Ultra-Processive UltraMarathonRT Kit Enables Consistent, Robust Amplification of Long RNAs in 80 Minutes with Very Low RNA Input. Branford, CT – RNAConnect, a pioneering life science reagent company, today announced the launch of the UltraMarathonRT® Two-Step RT-PCR Kit, a next-generation solution for researchers conducting RNA-to-cDNA conversion and amplification experiments. Designed for enhanced processivity, sensitivity, and fidelity, […]
BOSTON, United States and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today announced that Ross Muken, previously Chief Financial Officer (“CFO”) and Chief Operating Officer (“COO”), has been promoted to company President, effective November 5, 2024. George Cardoza has been appointed as the company’s new CFO. […]
New strategic partnership between UK Biobank, Genomics England, NHS England and Oxford Nanopore designed to: Advance biomedical research and translate discoveries for improved patient care Improve health outcomes by targeting novel genomic and epigenomic discoveries in cancer, human genetic disease and infectious disease Initial programme: to create an ‘early warning system’ for future pandemics across […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
